🇺🇸 Hemostatic Matrix in United States

14 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Post Procedural Complication — 4 reports (28.57%)
  2. Status Epilepticus — 2 reports (14.29%)
  3. Blood Bilirubin Increased — 1 report (7.14%)
  4. Blood Pressure Decreased — 1 report (7.14%)
  5. Death — 1 report (7.14%)
  6. End-Tidal Co2 Decreased — 1 report (7.14%)
  7. Hypotension — 1 report (7.14%)
  8. Ileus Paralytic — 1 report (7.14%)
  9. Intracranial Pressure Increased — 1 report (7.14%)
  10. Oxygen Saturation Decreased — 1 report (7.14%)

Source database →

Hemostatic Matrix in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Hemostatic Matrix approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Hemostatic Matrix in United States?

Hospital for Special Surgery, New York is the originator. The local marketing authorisation holder may differ — check the official source linked above.